Accurately Identify Fibromyalgia Early.
IsolateFibromyalgia™ is a breakthrough RNA blood test that can ‘rule in’ or ‘rule out’ a suspected diagnosis of fibromyalgia at the earliest sign of symptoms, within a week of receiving the patient sample in the laboratory.
Our test compares gene expression signatures for fibromyalgia to other autoimmune diseases, including rheumatoid arthritis and systemic lupus. By confirming the suspected autoimmune disease faster, doctors can initiate treatment earlier in the disease progression. Earlier treatment can help slow the illness and allow for better management of its long-term physical, emotional and financial effects.
Ready for Answers?
If you suspect your patient may have fibromyalgia, IsolateFibromyalgia™ will be available early 2018.
Stay up-to-date on our progress by subscribing to the IQuity Insights blog.